Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:628198rdf:typepubmed:Citationlld:pubmed
pubmed-article:628198lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:628198lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:628198lifeskim:mentionsumls-concept:C0030817lld:lifeskim
pubmed-article:628198lifeskim:mentionsumls-concept:C0549225lld:lifeskim
pubmed-article:628198pubmed:issue3lld:pubmed
pubmed-article:628198pubmed:dateCreated1978-4-26lld:pubmed
pubmed-article:628198pubmed:abstractTextThe clinical and electrophysiological findings in 2 men who had developed a myasthenic syndrome after taking penicillamine for rheumatoid arthritis will be described. The symptoms began with dysfunction of the eye muscles following a generalised muscle weakness. Course of illness after withdrawal of penicillamine was not uniform. In one of the patients a complete remission occurred within a year. The other became steadily worse and required continuous treatment with cholinesterase inhibitors. Electrophysiological examinations showed neuromuscular blockade, posttetanic exhaustion, posttetanic potentiation was found in one patient only. An immunopharmacological block of acetylcholine receptors induced by penicillamine is discussed from a pathogenetical point of view.lld:pubmed
pubmed-article:628198pubmed:languagegerlld:pubmed
pubmed-article:628198pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:628198pubmed:citationSubsetIMlld:pubmed
pubmed-article:628198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:628198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:628198pubmed:statusMEDLINElld:pubmed
pubmed-article:628198pubmed:monthFeblld:pubmed
pubmed-article:628198pubmed:issn0023-2173lld:pubmed
pubmed-article:628198pubmed:authorpubmed-author:StöhrMMlld:pubmed
pubmed-article:628198pubmed:authorpubmed-author:SchulzPPlld:pubmed
pubmed-article:628198pubmed:issnTypePrintlld:pubmed
pubmed-article:628198pubmed:day1lld:pubmed
pubmed-article:628198pubmed:volume56lld:pubmed
pubmed-article:628198pubmed:ownerNLMlld:pubmed
pubmed-article:628198pubmed:authorsCompleteYlld:pubmed
pubmed-article:628198pubmed:pagination139-44lld:pubmed
pubmed-article:628198pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-H...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-M...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-E...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-A...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-M...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-A...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-C...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-P...lld:pubmed
pubmed-article:628198pubmed:meshHeadingpubmed-meshheading:628198-M...lld:pubmed
pubmed-article:628198pubmed:year1978lld:pubmed
pubmed-article:628198pubmed:articleTitle[Myasthenic syndrome during penicillamine treatment (author's transl)].lld:pubmed
pubmed-article:628198pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:628198pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:628198pubmed:publicationTypeCase Reportslld:pubmed